01—Abstract
Summary
Summary of the 10-Q filed March 22, 2013. Cited figures are marked; the original filing is the authoritative source.
Quture International, Inc. (BRRN) filed its 10-Q for the quarter ended January 31, 2013, reporting significant financial challenges.
The company experienced a net loss of $1.92 million for the nine-month period, compared to $1.48 milliona in the prior year, with revenues declining to $21,000 from $40,900. Operating expenses also saw a slight increase. The balance sheet reflects a severe liquidity crunch, with cash and cash equivalents at a mere $3,186 and a working capital deficiency of approximately $2.97 million.
The company explicitly states that these conditions raise substantial doubt about its ability to continue as a going concern. Quture International's survival is contingent upon its ability to generate revenue and secure significant investment capital or loans.
Management is actively seeking funding through equity or debt offerings, but acknowledges the potential for dilution and the risk of business cessation if financing is unsuccessful. Investors should note the company's heavy reliance on external funding and its ongoing struggle to achieve profitability.
02—Key points
Key Highlights
- Net loss for the nine months ended January 31, 2013 was $1.92 million, an increase from $1.48 million in the prior year.
- Total revenue for the nine months ended January 31, 2013 was $21,000, a decrease from $40,900 in the prior year.
- Cash and cash equivalents stood at a critically low $3,186 as of January 31, 2013.
- The company reported a working capital deficiency of approximately $2.97 million at the end of the quarter.
- Management explicitly states that substantial doubt exists regarding the company's ability to continue as a going concern.
- The company's continuation depends on its ability to generate revenue and secure additional investment capital or loans.
- Total liabilities significantly exceeded total assets, indicating a severe financial deficiency.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2013filed March 22, 2013Financial Statements
Q1 FY2013 against Q1 FY2012
| Line item | Q1 FY2013Q1 FY2012 | Change |
|---|---|---|
| Revenue | $21K$41K | −48.7% |
| Gross Profit | $21K$41K | −48.7% |
| R&D Expenses | $91K— | — |
| SG&A Expenses | $149K$1.03M | −85.5% |
| Operating Income | -$1.42M-$1.37M | −2.9% |
| Interest Expense | -$16K-$101K | +83.6% |
| Net Income | -$348K-$1.14M | +69.5% |
| Shares Outstanding (Basic) | 2.24B2.10B | +6.6% |
05—Questions
Frequently Asked Questions
What is the company's current financial health?
Quture International, Inc. is facing significant financial distress. The company reported a substantial net loss for the nine-month period, revenues are minimal and declining, and cash reserves are critically low at $3,186. There is a significant working capital deficiency and accumulated deficit, leading management to state that there is substantial doubt about the company's ability to continue as a going concern.
What are the primary risks for investors?
The primary risk is the company's going concern status. Quture International is heavily reliant on securing additional funding through equity or debt offerings. If the company is unsuccessful in raising the necessary capital, it may be forced to cease operations, resulting in a total loss for investors. Additionally, any future financing may lead to significant dilution of existing shareholders' stakes.
What is the company's business and its progress?
Quture International develops medical software focused on measuring clinical performance and outcomes using analytics. The company has a partnership with InterSystems Corporation to leverage their technology platform. While the company has completed alpha and beta testing for its QualOptima product and conducted a clinical trial, it has not yet generated significant revenue from these efforts. The business model appears to be in a development and funding phase, with limited commercial traction to date.
What is the company's liquidity situation?
The company's liquidity is extremely poor. With only $3,186 in cash and cash equivalents at the end of the quarter, and significant liabilities, Quture International does not have sufficient funds to meet its operational needs for the next 12 months without additional financing. Current liabilities far exceed current assets.
06—Continue